http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2754802-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96cddc03da9e27cc0e82d4485078534c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-30 |
| filingDate | 2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9952eb57d90e41d02e4eedfc7afebfa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3627b005686d5c10fb3953dc511cb43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e36d6d0ece149cc0e6959db30ccee61c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79217d0da00217719f93a3d0d48fd160 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fcb38dd53044bbde540ba9689b60714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_106e70ce4d712445b5cac2e4112af408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8fe26a1b8ecd5b2ee8f281e1db72ee9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6148e0a4470b42499c45a7d2e39eb9db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31ac7086affc03651c6878d658a7c5d2 |
| publicationDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2754802-C1 |
| titleOfInvention | Method for predicting the risk of developing diseases that are causes of medical contraindications to working with harmful factors of metallurgical production |
| abstract | FIELD: industrial medicine.SUBSTANCE: invention relates to the field of medicine, in particular to occupational hygiene. To predict the risk of developing diseases that are the causes of medical contraindications to working with harmful factors of metallurgical production, buccal epithelial cells are taken, the drug is fixed and colored according to Romanowsky-Giemsa. The number of cells with micronuclei and cells with such nuclear disorders as the phenomenon of "broken egg", karyopycnosis, karyorexis, binuclear cells, amitosis, cells with nuclear membrane lysis is counted. The integral index of proliferation, the apoptic index and the coefficient of frequency of cellular anomalies (CFCA) are determined. With the values of the CFCA from 0.81 to 1.07 relative units, a low risk is predicted. At values of the CFCA from 0.65 to 0.8 relative units or from 1.071 to 1.28 relative units, the average risk is predicted. If the values of the CFCA are less than 0.65 relative units or more than 1.28 relative units, a high risk is predicted.EFFECT: method is safe, non-invasive, accessible, increases the accuracy of the forecast due to the integral quantitative expression of the balance of the processes of proliferation and apoptosis, allows you to select groups of people for timely preventive measures.1 cl, 1 tbl, 9 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2791645-C1 |
| priorityDate | 2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.